Loading…
Hester Biosciences (HESTERBIO)₹2,309−2.39%Pharmaceuticals
At the end of the Jun 2026 quarter, Hester Biosciences' shareholders were: promoters 53.78%, FIIs 0.31%, public 45.91%. Promoter holding is unchanged on the quarter. FII holding is down 0.20 percentage points from 0.51% a year earlier. 0.00% of promoter shares were pledged. It had 11,964 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 53.78% | 53.78% | 53.78% | 53.78% | 53.78% | 53.78% | 53.78% | 53.78% | 53.78% | 53.78% | 53.78% | 53.78% |
| FIIs | 0.42% | 0.43% | 0.43% | 0.52% | 0.61% | 0.59% | 0.87% | 0.51% | 0.53% | 0.52% | 0.38% | 0.31% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.02% | 0.02% | 0.02% | 0.00% | 0.01% | 0.00% | 0.00% |
| Public | 45.80% | 45.79% | 45.79% | 45.70% | 45.61% | 45.61% | 45.33% | 45.69% | 45.69% | 45.69% | 45.84% | 45.91% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 13,346 | 13,454 | 12,847 | 11,308 | 11,541 | 11,476 | 11,856 | 11,813 | 12,263 | 12,606 | 12,376 | 11,964 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Rajiv Dinesh Gandhi | Promoter | 10.50% | 0.00 |
| Sanjiv Dinesh Gandhi | Promoter | 8.25% | 0.00 |
| Nina Rajiv Gandhi | Promoter | 8.20% | 0.00 |
| Shaila Bhupendra Gandhi | Promoter | 5.79% | 0.00 |
| Ravin Gandhi | Promoter | 4.75% | 0.00 |
| Bela Gandhi | Promoter | 4.69% | 0.00 |
| Bhupendra Vithaldas Gandhi | Promoter | 4.66% | 0.00 |
| Kuntal Hasmukhlal Shah | Public | 3.18% | 0.00 |
| Biolink Healthcare Limited | Promoter | 2.90% | 0.00 |
| Manish Jain | Public | 2.89% | 0.00 |
| Anup Chandravadan Kapadia | Promoter | 2.69% | 0.00 |
| Darshna Dinesh Kapadia | Public | 1.83% | 0.00 |
| Sandeep Shantilal Gala | Public | 1.29% | 0.00 |
| Vinay Shah | Public | 1.29% | 0.00 |
| Manish Jain (HUF) | Public | 1.22% | 0.00 |
| Jagrut Prataprai Gandhi | Public | 1.17% | 0.00 |
| Manish Prataprai Gandhi | Public | 1.17% | 0.00 |
| Investor Education and Protection Fund (IEPF) | Public | 1.01% | 0.00 |
| Hester Coatings LLP | Promoter | 0.74% | 0.00 |
| Hester Diagnostics Private Limited | Promoter | 0.28% | 0.00 |
| Hetal Sanjiv Gandhi | Promoter | 0.23% | 0.00 |
| Yash Rajiv Gandhi | Promoter | 0.09% | 0.00 |
Promoters held 53.78% of Hester Biosciences at the end of the Jun 2026 quarter, the same as a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 0.31% (down 0.07 percentage points from 0.38% a quarter earlier) and domestic institutions (DIIs) held 0.00% (unchanged at 0.00% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Hester Biosciences had 11,964 shareholders at the end of the Jun 2026 quarter, against 11,813 a year earlier.
Kuntal Hasmukhlal Shah (Public) held 3.18% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.